Pfizer and Sangamo initiate dosing in Phase III haemophilia A trial
Haemophilia results in deficiency of a protein needed for blood clotting. Credit: allinonemovie from Pixabay.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
-
Cellular Technology Limited
Cellular Technology Limited (CTL) is a global biotechnology company specialized...
About
Cellular Technology Limited (CTL) is a global biotechnology company specialized in the development, use, and manufacture of standardized tools for cellular immune assays.
FollowMake an Enquiry
-
VaLea Clinical Trials
VaLea Clinical Trials specialises in providing convenient patient-centric services for...
About
VaLea Clinical Trials specialises in providing convenient patient-centric services for clinical trials in the home or alternate-site settings, based in Vienna, Austria.
FollowMake an Enquiry
-
CSM, a Clinigen company
CSM, a Clinigen company, focuses on clinical trial supplies and...
About
CSM, a Clinigen company, focuses on clinical trial supplies and biological sample management services.
FollowMake an Enquiry